Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Pediatrics ; 146(2)2020 08.
Article in English | MEDLINE | ID: mdl-32611807

ABSTRACT

BACKGROUND AND OBJECTIVES: Vancomycin remains one of the most commonly prescribed antibiotics in NICUs despite recommendations to limit its use for known resistant infections. Baseline data revealing substantially higher vancomycin use in our NICU compared to peer institutions informed our quality improvement initiative. Our aim was to reduce the vancomycin prescribing rate in neonates hospitalized in our NICU by 50% within 1 year and sustain for 1 year. METHODS: In the 60-bed level IV NICU of an academic referral center, we used a quality improvement framework to develop key drivers and interventions including (1) physician education with benchmarking antibiotic prescribing rates; (2) pharmacy-initiated 48-hour antibiotic time-outs on rounds; (3) development of clinical pathways to standardize empirical antibiotic choices for early-onset sepsis, late-onset sepsis, and necrotizing enterocolitis; coupled with (4) daily prospective audit with feedback from the antimicrobial stewardship program. RESULTS: We used statistical process u-charts to show vancomycin use declined from 112 to 38 days of therapy per 1000 patient-days. After education, pharmacy-initiated 48-hour time-outs, and development of clinical pathways, vancomycin use declined by 29%, and by an additional 52% after implementation of prospective audit with feedback. Vancomycin-associated acute kidney injury also declined from 1.4 to 0.1 events per 1000 patient-days. CONCLUSIONS: Through a sequential implementation approach of education, standardization of care with clinical pathways, pharmacist-initiated 48-hour time-outs, and prospective audit with feedback, vancomycin days of therapy declined by 66% over a 1-year period and has been sustained for 1 year.


Subject(s)
Antimicrobial Stewardship/statistics & numerical data , Inappropriate Prescribing/prevention & control , Intensive Care Units, Neonatal/statistics & numerical data , Vancomycin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Antimicrobial Stewardship/organization & administration , Brazil , Critical Pathways , Enterocolitis, Necrotizing/drug therapy , Hospitals, Pediatric/statistics & numerical data , Hospitals, Urban/statistics & numerical data , Humans , Inappropriate Prescribing/statistics & numerical data , Infant, Newborn , Infant, Newborn, Diseases/drug therapy , Pharmacy Service, Hospital/organization & administration , Prospective Studies , Quality Improvement , Sepsis/drug therapy
2.
J Pediatr ; 223: 199-203.e1, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32405091

ABSTRACT

Despite worldwide spread of severe acute respiratory syndrome coronavirus-2, few publications have reported the potential for severe disease in the pediatric population. We report 177 infected children and young adults, including 44 hospitalized and 9 critically ill patients, with a comparison of patient characteristics between infected hospitalized and nonhospitalized cohorts, as well as critically ill and noncritically ill cohorts. Children <1 year and adolescents and young adults >15 years of age were over-represented among hospitalized patients (P = .07). Adolescents and young adults were over-represented among the critically ill cohort (P = .02).


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Hospitalization , Pneumonia, Viral/epidemiology , Adolescent , Age Distribution , Asthma/epidemiology , COVID-19 , Child , Child, Preschool , Cohort Studies , Comorbidity , Coronavirus Infections/diagnosis , Cough/virology , Critical Illness , District of Columbia/epidemiology , Dyspnea/virology , Female , Fever/virology , Humans , Infant , Infant, Newborn , Male , Mucocutaneous Lymph Node Syndrome/complications , Pandemics , Pharyngitis/virology , Pneumonia, Viral/diagnosis , Respiration, Artificial/statistics & numerical data , Retrospective Studies , SARS-CoV-2 , Systemic Inflammatory Response Syndrome/virology , Young Adult
4.
J Pediatr ; 208: 214-220.e2, 2019 05.
Article in English | MEDLINE | ID: mdl-30879729

ABSTRACT

OBJECTIVES: To determine risk factors for complications in children with Staphylococcus aureus (S aureus) bacteremia, including methicillin resistance. STUDY DESIGN: Single center, retrospective cohort study of children ≤18 years of age hospitalized with S aureus bacteremia. We compared clinical characteristics and outcomes between those with methicillin-sensitive S aureus (MSSA) and methicillin-resistant S aureus (MRSA) bacteremia. Multivariate regression models identified risk factors associated with developing complications and with longer duration of bacteremia. RESULTS: We identified 394 episodes of S aureus bacteremia, 279 (70.8%) with MSSA, and 115 (29.2%) with MRSA. Primary site of infection was catheter-related in 34%, musculoskeletal in 30%, skin/soft tissue in 10.2%, pneumonia in 6.4%, and endovascular in 6.6%. Eight children (2.0%) died within 30 days because of S aureus bacteremia, 15 (3.5%) had recurrence within 30 days, and 38 (9.6%) had complications including septic emboli or a metastatic focus of infection. Methicillin resistance was associated with development of a complication (aOR 3.31; 95% CI 1.60-6.85), and catheter-related infections were less likely to be associated with a complication (aOR 0.40; 95% CI 0.15-1.03). In a Poisson regression analysis on duration of bacteremia, methicillin resistance, musculoskeletal infection, endovascular infection, black race, and delayed intervention for source control were significantly associated with longer duration of bacteremia. CONCLUSIONS: In this cohort of children with S aureus bacteremia, MRSA infections ere associated with longer duration of bacteremia and a higher likelihood of complications.


Subject(s)
Bacteremia/complications , Bacteremia/microbiology , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections/complications , Staphylococcal Infections/microbiology , Anti-Bacterial Agents/therapeutic use , Catheter-Related Infections/complications , Child , Child, Preschool , Cross Infection/complications , Female , Humans , Infant , Male , Methicillin Resistance , Multivariate Analysis , Poisson Distribution , Regression Analysis , Retrospective Studies , Risk Factors
5.
Pediatr Infect Dis J ; 37(9): 901-907, 2018 09.
Article in English | MEDLINE | ID: mdl-29561517

ABSTRACT

BACKGROUND: Although Italian pediatric antimicrobial prescription rates are among the highest in Europe, little action has been taken to improve the appropriateness of antimicrobial prescriptions. The primary aim of this study was to assess changes in antibiotic prescription before and after acute otitis media (AOM) and group A streptococcus (GAS) pharyngitis Clinical Pathway (CP) implementation; secondary aims were to compare treatment failures and to assess change in the total antibiotics costs before and after CP implementation. METHODS: Pre-post quasi-experimental study comparing the 6-month period before CP implementation (baseline period: October 15, 2014, through April 15, 2015) to the 6 months after intervention (postintervention: October 15, 2015, through April 15, 2016). RESULTS: Two hundred ninety-five pre- and 278 postintervention emergency department visits were associated with AOM. After CP implementation, there was an increase in "wait and see" approach and a decrease in overall prescription of broad-spectrum antibiotics from 53.2% to 32.4% (P < 0.001). One hundred fifty-one pre- and 166 postimplementation clinic visits were associated with GAS pharyngitis, with a decrease in broad-spectrum prescription after CP implementation (46.4% vs. 6.6%; P < 0.001). For both conditions, no difference was found in treatment failure, and total antibiotics cost was significantly reduced after CP implementation, with a decrease especially in broad-spectrum antibiotics costs. CONCLUSIONS: A reduction in broad-spectrum antibiotic prescriptions and a reduction in the total cost of antibiotics for AOM and GAS pharyngitis along with an increase in "wait and see" prescribing for AOM indicate effectiveness of CP for antimicrobial stewardship in this setting.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Critical Pathways , Drug Prescriptions/statistics & numerical data , Otitis Media/drug therapy , Pharyngitis/drug therapy , Treatment Failure , Acute Disease , Adolescent , Anti-Bacterial Agents/economics , Antimicrobial Stewardship/economics , Child , Child, Preschool , Emergency Service, Hospital/statistics & numerical data , Female , Humans , Infant , Italy , Male , Otitis Media/microbiology , Pharyngitis/microbiology , Practice Patterns, Physicians'/statistics & numerical data , Streptococcus pyogenes/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL